zidovudine has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandrasekar, S; Idris, MM; Kavitha, M; Mahesh Kumar, J; Mainkar, PS; Meghah, V; Nagesh, N; Pal, B; Reddy, CR; Srinivas, G; Vinay Kumar, P | 1 |
| Bouayadi, K; Cazaux, C; Fons, P; Hoffmann, JS; Reynes, JP; Tiraby, M | 1 |
2 other study(ies) available for zidovudine and B16 Melanoma
| Article | Year |
|---|---|
Phenyl 1,2,3-triazole-thymidine ligands stabilize G-quadruplex DNA, inhibit DNA synthesis and potentially reduce tumor cell proliferation over 3'-azido deoxythymidine.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Click Chemistry; DNA Fragmentation; DNA, Neoplasm; G-Quadruplexes; Humans; Ligands; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Skin Neoplasms; Thymidine; Triazoles; Tumor Burden; Zidovudine | 2013 |
Overexpression of DNA polymerase beta sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine.
Topics: Animals; CHO Cells; Cricetinae; Deoxycytidine; DNA Polymerase I; DNA Replication; Melanoma, Experimental; Neoplasm Proteins; Thymidine Kinase; Transfection; Zidovudine | 1997 |